Intravenous pulse cyclophosphamide in the treatment of interstitial lung disease due to collagen vascular diseases

Abstract

I.v. pulse CYC proved to be an effective and well-tolerated treatment in these patients. Since it appears to target mainly the inflammatory component of the disease, it should be reserved for progressive ILD featuring indices of high inflammatory activity.